CN113200856A - Trifluoromethyl propylene compound and preparation method and application thereof - Google Patents

Trifluoromethyl propylene compound and preparation method and application thereof Download PDF

Info

Publication number
CN113200856A
CN113200856A CN202110543451.XA CN202110543451A CN113200856A CN 113200856 A CN113200856 A CN 113200856A CN 202110543451 A CN202110543451 A CN 202110543451A CN 113200856 A CN113200856 A CN 113200856A
Authority
CN
China
Prior art keywords
methacrylate
hydroxy
methyl
allyl alcohol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110543451.XA
Other languages
Chinese (zh)
Other versions
CN113200856B (en
Inventor
解沛忠
李博文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN202110543451.XA priority Critical patent/CN113200856B/en
Publication of CN113200856A publication Critical patent/CN113200856A/en
Application granted granted Critical
Publication of CN113200856B publication Critical patent/CN113200856B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/14Preparation of carboxylic acid esters from carboxylic acid halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/65Halogen-containing esters of unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Disclosure of the inventionA trifluoromethyl propylene compound and its preparing process and application are disclosed. The invention directly uses allyl alcohol as raw material, selects CF3SO2Na is used as a trifluoromethylating reagent, a metal-free and cheap photo-oxidation-reduction catalyst is used, and a by-product SO generated in situ under the catalysis of an organic photo-oxidation-reduction agent2Is reused to activate the C-OH bond, thereby allowing the reaction to occur in an environmentally friendly manner under mild conditions. The allyl alcohol used in the preparation method is a Morita-Baylis-Hillman alcohol allyl alcohol raw material with simple synthesis and high conversion rate, the applicable substrate range is wide, and the preparation cost is low; in addition, the preparation method has simple steps, and has the characteristics of convenient operation, environmental protection, excellent stereoselectivity and tolerance of broad-spectrum functional groups; the trifluoromethyl propenyl compound of the invention is the relevant CF for preparation3The universal precursor of the molecule has potential pharmaceutical activity and biological activity, and can be widely applied to biological and pharmaceutical active molecules.

Description

Trifluoromethyl propylene compound and preparation method and application thereof
Technical Field
The invention belongs to the technical field of organic chemical synthesis, and particularly relates to a trifluoromethyl propenyl compound and a preparation method and application thereof.
Background
The development of novel synthetic fluorination reactions is of great significance in agriculture, medicine and material chemistry. Fluorine and fluorine-containing compounds can affect the properties of organic compounds, whose electronegativity, all hydrophobicity/lipophilicity and electrostatic interactions can significantly affect chemical reactions. Even a fluorine atom can completely change the properties of a compound.
Among them, fluorine-containing drugs have been invested in a large number of resources in academia and industry, and the properties of drugs can be intentionally improved by selective fluorination, at least the biological half-life of drugs can be extended by hindering oxidative metabolism, and bioabsorption can be increased by lipophilic effects. According to investigation, a large number of fluorine-containing bioactive drug compounds are identified and confirmed, and the fluorine-containing compounds have great application potential. In particular, compounds having trifluoromethylpropenyl substitution are the preparation of the relevant CF3The universal precursor of the molecule has wide application prospect.
The synthesis of trifluoromethyl acrylic compounds is currently carried out by means of a superstoichiometric transition metal catalyst and a toxic or expensive high-valent iodine reagent, the olefins used being frequently highly reactive, pre-functionalized esters, halogenated hydrocarbons and the like. The method has harsh reaction conditions, depends on transition metal catalysis, is complex to treat after the reaction, and can also generate quantitative byproduct halogen salt/high-salinity wastewater. Therefore, from an environmental and economic point of view, it is very attractive to develop an energy-saving and efficient green synthesis method using non-toxic, cheap, readily available and relatively environmentally harmless raw materials.
Disclosure of Invention
The invention aims to provide a preparation method of a trifluoromethyl propylene compound, and aims to solve the problems that the existing method is harsh in reaction conditions, depends on transition metal catalysis, is complicated in subsequent treatment of reaction, and can generate quantitative byproduct halogen salt/high-salinity wastewater.
Still another object of the present invention is to provide a trifluoromethylacryl-based compound obtained by the above-mentioned preparation method.
Another object of the present invention is to provide the use of the above-mentioned trifluoromethylacryl based compound.
The present invention is achieved by a method for producing a trifluoromethylacryl-based compound, comprising the steps of:
(1) sequentially adding allyl alcohol, sodium trifluoromethanesulfonate and 3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate into a reaction solvent, and stirring and reacting for 4 hours under the conditions of inert gas atmosphere, blue light irradiation and room temperature to obtain a reaction solution; wherein the molar volume ratio of the allyl alcohol, the sodium trifluoromethanesulfonate, the 3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate to the reaction solvent is (0.2-0.4) mmol: (0.3-0.6) mmol: (0.008-0.016) mmol: (3-6) mL;
(2) removing the reaction solvent in the reaction solution, and purifying by thin layer chromatography, wherein the developing agent system is petroleum ether/ethyl acetate, so as to obtain the trifluoromethyl acrylic compound.
Preferably, in step (1), the inert gas is argon.
Preferably, in step (1), the allyl alcohol is Morita-Baylis-Hillman alcohol allyl alcohol.
Preferably, the allyl alcohol is selected from the group consisting of methyl 2-hydroxy (phenyl) methacrylate, methyl 2-hydroxy (4-fluorobenzene) methacrylate, methyl 2-hydroxy (4-trifluoromethylbenzene) methacrylate, methyl 2-hydroxy (4-nitrobenzene) methacrylate, methyl 2-hydroxy (4-carboxaldehydebenzene) methacrylate, methyl 2-hydroxy (4-methoxybenzene) methacrylate, methyl 2-hydroxy (4-tert-butylbenzene) methacrylate, methyl 2-hydroxy (3-fluorobenzene) methacrylate, methyl 2-hydroxy (2-chlorobenzene) methacrylate, methyl 2-hydroxy (3, 5-dimethylbenzene) methacrylate, methyl 2-hydroxy (naphthalen-1-yl) methacrylate, methyl 2-hydroxy (4-fluorobenzene) methacrylate, and mixtures thereof, Any one of methyl 2-hydroxy (pyridin-3-yl) methacrylate, methyl 2-hydroxy (thiophen-2-yl) methacrylate, ethyl 2-hydroxy (phenyl) methacrylate, tert-butyl 2-hydroxy (phenyl) methacrylate, menthol 2-hydroxy- (2, 4-dichlorophenyl) methacrylate, cholesterol 2-hydroxy- (2, 4-dichlorophenylmethyl) acrylate, and diacetone galactose 2-hydroxy- (2, 4-dichlorophenyl) methacrylate.
Preferably, in the step (1), the reaction solvent is selected from any one of dimethyl sulfoxide, N-dimethylformamide, acetone and acetonitrile.
Preferably, the reaction solvent is acetonitrile.
The invention further provides a trifluoromethyl propylene compound obtained by the preparation method.
The invention further discloses application of the trifluoromethyl propenyl compound in preparing frameworks of biologically and pharmaceutically active molecules.
The invention overcomes the defects of the prior art and provides a trifluoromethyl propylene compound and a preparation method and application thereof3SO2Na is used as a trifluoromethylating reagent, a metal-free and cheap photo-oxidation-reduction catalyst is used, and a by-product SO generated in situ under the catalysis of an organic photo-oxidation-reduction agent2Is reused to activate the-OH bond, thereby allowing the reaction to occur in an environmentally friendly manner under mild conditions.
Compared with the defects and shortcomings of the prior art, the invention has the following beneficial effects:
(1) the allyl alcohol used in the preparation method is a Morita-Baylis-Hillman alcohol allyl alcohol raw material with simple synthesis and high conversion rate, and the applicable substrate range is wide, for example, various substituted phenyl and alkyl can be on the allyl alcohol, so the preparation method has the characteristic of low preparation cost; in addition, the preparation method has simple steps, and has the characteristics of convenient operation, environmental protection, excellent stereoselectivity and tolerance of broad-spectrum functional groups;
(2) the trifluoromethyl propenyl compound is a general precursor for preparing related CF3 molecules, has potential pharmaceutical activity and biological activity, and can be widely applied to biological and pharmaceutical active molecules (such as antitumor drugs).
Drawings
FIG. 1 is a NMR spectrum of methyl (E) -2-benzylidene-4, 4, 4-trifluorobutyrate in example of the present invention;
FIG. 2 is a NMR carbon spectrum of methyl (E) -2-benzylidene-4, 4, 4-trifluorobutyrate in example of the present invention;
FIG. 3 is the NMR fluorine spectrum of (E) -methyl 2-benzylidene-4, 4, 4-trifluorobutyrate in the example of the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
(1) In a 10mL Schlenk tube, under argon atmosphere, adding 0.2mmol 2-hydroxy (phenyl) methyl methacrylate, 0.3mmol sodium trifluoromethanesulfonate, 0.008mmol3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate, adding 3mL acetonitrile, and stirring under argon, room temperature and 18W blue light irradiation for reaction, wherein the reaction equation is as follows:
Figure BDA0003072651270000041
(2) after TLC monitoring reaction is completed, vacuum rotary evaporator is used to remove solvent, thin layer chromatography is used to separate product, developing agent is petroleum ether/ethyl acetate system, product is light yellow liquid (E) -2-benzylidene-4, 4, 4-trifluoro methyl butyrate, yield is 71%.
Performing nuclear magnetic resonance test on (E) -2-benzylidene-4, 4, 4-trifluorobutyric acid methyl ester, wherein as shown in figures 1-3, figure 1 is a nuclear magnetic resonance hydrogen spectrum of (E) -2-benzylidene-4, 4, 4-trifluorobutyric acid methyl ester; FIG. 2 is a NMR carbon spectrum of methyl (E) -2-benzylidene-4, 4, 4-trifluorobutyrate; FIG. 3 is a nuclear magnetic resonance fluorine spectrum of methyl (E) -2-benzylidene-4, 4, 4-trifluorobutyrate.
Example 2
(1) In a 10mL Schlenk tube, under an argon atmosphere, 0.4mmol of 2-hydroxy (2, 4-dichlorophenyl) methylcyclohex-2-en-1-one, 0.6mmol of sodium trifluoromethylsulfinate, 0.016mmol of 3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate, 6mL of acetonitrile are added, and the reaction is stirred under argon, room temperature and 18W of blue light irradiation, the reaction equation is as follows:
Figure BDA0003072651270000051
(2) after TLC monitoring reaction is completed, vacuum rotary evaporator is used to remove solvent, thin layer chromatography is used to separate product, developing agent is petroleum ether/ethyl acetate system, product is light yellow liquid (E) -2- (2, 4-dichlorobenzylidene) -3- (trifluoromethyl) cyclohex-1-one, yield is 74%.
Example 3
This example is substantially the same as example 1 above, except that 10mmol of methyl 2-hydroxy (phenyl) methacrylate, 15mmol of sodium trifluoromethylsulfinate, 0.4mmol of 3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate and 150mL of acetonitrile were charged in a 250mL round-bottomed flask and the reaction was stirred under argon at room temperature under 18W of blue light irradiation to obtain 1.76g of methyl (E) -2-benzylidene-4, 4, 4-trifluorobutyrate with a yield of 72%.
Example 4
This example is essentially the same as example 1 above, except that the allyl alcohol used is one with a natural product menthol molecular structure, and the allyl alcohol is synthesized by the steps of:
(1) adding menthol into a dichloromethane solution under the condition of room temperature under the protection of argon, adding triethylamine at the temperature of 0 ℃, and stirring for 0.5 h. Dripping a dichloromethane solution of acryloyl chloride into the reaction solution at the temperature of 0 ℃, and stirring and reacting for 12 hours at room temperature to obtain a reaction mixture; wherein the mol ratio of the menthol to the triethylamine to the acryloyl chloride is 1.2: 2: 1; the reaction equation is:
Figure BDA0003072651270000052
(2) the reaction mixture was quenched by addition of saturated ammonium chloride solution, extracted 3 times with ether, the organic phases were combined, dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and the residue was purified by column silica gel chromatography with petroleum ether and ethyl acetate (PE/EA) to give menthyl acrylate as a colorless liquid in 93% yield.
(3) Under the protection of argon and at room temperature, 2, 4-dichlorobenzaldehyde, acrylic acid menthol ester and triethylene diamine are mixed, and stirred at room temperature for 1 week. Obtaining a reaction mixture; wherein the molar ratio of the 2, 4-dichlorobenzaldehyde to the menthol acrylate to the triethylene diamine is 1: 1.2: 0.5;
Figure BDA0003072651270000061
(4) the reaction mixture was purified by column silica gel chromatography with petroleum ether and ethyl acetate (PE/EA) to give menthyl 2- (hydroxy- (2, 4-dichlorophenyl) meth) acrylate as a colorless liquid in 89% yield.
This example is essentially the same as example 1 above, except that the allyl alcohol is the menthyl 2-hydroxy (2, 4-dichlorophenyl) methacrylate obtained above, and the reaction equation is:
Figure BDA0003072651270000062
example 5
This example is essentially the same as example 1 above, except that the allyl alcohol used is one with a molecular structure of the natural product cholesterol, and the allyl alcohol is synthesized by the steps of:
(1) under the protection of argon and at room temperature, the cholesterol is added into a dichloromethane solution, the triethylamine is added at the temperature of 0 ℃, and the mixture is stirred for 0.5 h. Dripping a dichloromethane solution of acryloyl chloride into the reaction solution at the temperature of 0 ℃, and stirring and reacting for 12 hours at room temperature to obtain a reaction mixture; wherein the mol ratio of the cholesterol to the triethylamine to the acryloyl chloride is 1.2: 2: 1; the reaction equation is:
Figure BDA0003072651270000071
(2) the reaction mixture was quenched by adding saturated ammonium chloride solution, extracted 3 times with ether, the organic phases were combined, dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and the residue was purified by column silica gel chromatography with petroleum ether and ethyl acetate (PE/EA) to give cholesterol acrylate as a white solid in 61% yield.
(3) Under the protection of argon and at room temperature, dissolving 2, 4-dichlorobenzaldehyde, acrylic acid cholesterol ester and triethylene diamine in tetrahydrofuran, and stirring at room temperature for 1 week to obtain a reaction mixture; wherein the molar ratio of the 2, 4-dichlorobenzaldehyde to the acrylic acid cholesterol ester to the triethylene diamine is 1: 1.2: 0.5;
Figure BDA0003072651270000072
(4) the reaction mixture was removed of the solvent under reduced pressure and the residue was purified by column silica gel chromatography with petroleum ether and ethyl acetate (PE/EA) to give cholesterol 2- (hydroxy- (2, 4-dichlorophenyl) meth) acrylate as a white solid in 58% yield.
This example is essentially the same as example 1 above, except that allyl alcohol is the 2-hydroxy ((2, 4-dichlorophenyl) cholesterol methacrylate obtained above, the reaction equation is:
Figure BDA0003072651270000073
example 6
This example is substantially the same as example 1 above, except that the allyl alcohol used is one having a natural product diacetone galactose molecular structure, and the allyl alcohol is synthesized by the steps of:
(1) adding diacetone galactose into dichloromethane solution under the condition of room temperature under the protection of argon, adding triethylamine at the temperature of 0 ℃, and stirring for 0.5 h. Dripping a dichloromethane solution of acryloyl chloride into the reaction solution at the temperature of 0 ℃, and stirring and reacting for 12 hours at room temperature to obtain a reaction mixture; wherein the molar ratio of diacetone galactose to triethylamine to acryloyl chloride is 1.2: 2: 1; the reaction equation is:
Figure BDA0003072651270000081
(2) the reaction mixture was quenched by addition of saturated ammonium chloride solution, extracted 3 times with ether, the organic phases were combined, dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and the residue was purified by column silica gel chromatography with petroleum ether and ethyl acetate (PE/EA) to give diacetone galactose acrylate as a white solid in a yield of 95%.
(3) Under the protection of argon and at room temperature, dissolving 2, 4-dichlorobenzaldehyde, diacetone galactosyl acrylate and triethylene diamine in tetrahydrofuran, and stirring at room temperature for 1 week to obtain a reaction mixture; wherein the molar ratio of the 2, 4-dichlorobenzaldehyde to the diacetone galactose acrylate to the triethylene diamine is 1: 1.2: 0.5;
Figure BDA0003072651270000082
(4) the reaction mixture was freed of solvent under reduced pressure and the residue was purified by column silica gel chromatography with petroleum ether and ethyl acetate (PE/EA) to give diacetone galactose 2- (hydroxy- (2, 4-dichlorophenyl) meth) acrylate as a white solid in 94% yield.
This example is essentially the same as example 1 above, except that allyl alcohol is the 2-hydroxy diacetone galactose ((2, 4-dichlorophenyl) methacrylate) obtained above, the reaction equation being:
Figure BDA0003072651270000083
the above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.

Claims (8)

1. A method for producing a trifluoromethylacryl-based compound, comprising the steps of:
(1) sequentially adding allyl alcohol, sodium trifluoromethanesulfonate and 3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate into a reaction solvent, and stirring and reacting for 4 hours under the conditions of inert gas atmosphere, blue light irradiation and room temperature to obtain a reaction solution; wherein the molar volume ratio of the allyl alcohol, the sodium trifluoromethanesulfonate, the 3, 6-di-tert-butyl-9-mesityl-10-phenylacridine-10-tetrafluoroborate to the reaction solvent is (0.2-0.4) mmol: (0.3-0.6) mmol: (0.008-0.016) mmol: (3-6) mL;
(2) removing the reaction solvent in the reaction solution, and purifying by thin layer chromatography, wherein the developing agent system is petroleum ether/ethyl acetate, so as to obtain the trifluoromethyl acrylic compound.
2. The method of producing a trifluoromethylacryl-based compound according to claim 1, wherein in the step (1), the inert gas is argon.
3. The method of producing a trifluoromethylacrylic compound according to claim 1, wherein in the step (1), the allyl alcohol is Morita-Baylis-Hillman alcohol allyl alcohol.
4. The method of producing a trifluoromethylacrylic compound according to claim 3, wherein the allyl alcohol is selected from the group consisting of methyl 2-hydroxy (phenyl) methacrylate, methyl 2-hydroxy (4-fluorobenzene) methacrylate, methyl 2-hydroxy (4-trifluoromethylbenzene) methacrylate, methyl 2-hydroxy (4-nitrobenzene) methacrylate, methyl 2-hydroxy (4-carboxaldehydebenzene) methacrylate, methyl 2-hydroxy (4-methoxybenzene) methacrylate, methyl 2-hydroxy (4-tert-butylbenzene) methacrylate, methyl 2-hydroxy (3-fluorobenzene) methacrylate, methyl 2-hydroxy (2-chlorobenzene) methacrylate, methyl 2-hydroxy (3, 5-dimethylbenzene) methacrylate, methyl 2-hydroxy (4-nitrobenzene) methacrylate, methyl tert-butyl methacrylate, methyl 2-hydroxy (4-nitrobenzene) methacrylate, methyl-propyl methacrylate, methyl ester, methyl methacrylate, methyl acrylate, and methyl acrylate, any one of methyl 2-hydroxy (naphthalen-1-yl) methacrylate, methyl 2-hydroxy (pyridin-3-yl) methacrylate, methyl 2-hydroxy (thiophen-2-yl) methacrylate, ethyl 2-hydroxy (phenyl) methacrylate, tert-butyl 2-hydroxy (phenyl) methacrylate, menthol 2-hydroxy- (2, 4-dichlorophenyl) methacrylate, cholesterol 2-hydroxy- (2, 4-dichlorophenyl) methacrylate, and diacetone galactose 2-hydroxy- (2, 4-dichlorophenyl) methacrylate.
5. The method of producing a trifluoromethylacryl-based compound according to claim 1, wherein in the step (1), the reaction solvent is selected from any one of dimethylsulfoxide, N-dimethylformamide, acetone, and acetonitrile.
6. The method for producing a trifluoromethylacryl-based compound according to claim 5, wherein the reaction solvent is acetonitrile.
7. A trifluoromethylacryl-based compound obtained by the process according to any one of claims 1 to 6.
8. Use of the trifluoromethylpropenyl compound of claim 7 for the preparation of scaffolds for biologically and pharmaceutically active molecules.
CN202110543451.XA 2021-05-19 2021-05-19 Trifluoromethyl propylene compound and preparation method and application thereof Active CN113200856B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110543451.XA CN113200856B (en) 2021-05-19 2021-05-19 Trifluoromethyl propylene compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110543451.XA CN113200856B (en) 2021-05-19 2021-05-19 Trifluoromethyl propylene compound and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN113200856A true CN113200856A (en) 2021-08-03
CN113200856B CN113200856B (en) 2022-06-07

Family

ID=77031701

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110543451.XA Active CN113200856B (en) 2021-05-19 2021-05-19 Trifluoromethyl propylene compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113200856B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114805012A (en) * 2022-06-17 2022-07-29 陇东学院 Synthesis method of allylic trifluoromethyl compound

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARVIND KUMAR YADAV,ET AL.,: ""Visible light enabled γ -trifluoromethylation of Baylis- Hillman acetates: stereoselective synthesis of trisubstituted alkenes"", 《ORG. CHEM. FRONT》 *
BOWEN LI,ET AL.,: ""Visible-Light-Induced Tri fl uoromethylation of Allylic Alcohols"", 《ORG. LETT.》 *
HONG-LI HUANG,ET AL.,: ""Metal-Free Direct Aryltrifluoromethylation of Allylic Alcohols with Langlois’ Reagent through Concomitant 1,2-Aryl Migration"", 《ASIAN J. ORG. CHEM.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114805012A (en) * 2022-06-17 2022-07-29 陇东学院 Synthesis method of allylic trifluoromethyl compound

Also Published As

Publication number Publication date
CN113200856B (en) 2022-06-07

Similar Documents

Publication Publication Date Title
Ni et al. A Remarkably Efficient Fluoroalkylation of Cyclic Sulfates and Sulfamidates with PhSO2CF2H: Facile Entry into b-Difluoromethylated or b-Difluoromethylenated Alcohols and Amines
CN107573267B (en) Trifluoromethyl-containing alkyl sulfonyl fluoride compound, and preparation method and application thereof
Lepore et al. Recent advances in heterolytic nucleofugal leaving groups
JP5669579B2 (en) Method for organocatalytic activation of carboxylic acids for chemical reactions using ortho-substituted arylboronic acids
CN113200856B (en) Trifluoromethyl propylene compound and preparation method and application thereof
EP3063154B1 (en) Cross-coupling of unactivated secondary boronic acids
CN110669001B (en) Synthetic method of 3-fluoro-4-halogeno-5-methoxypyridine
CN110885301A (en) Biaryl axial chiral compound and preparation method thereof
CN105985292B (en) A kind of asymmetry catalysis synthesis γ-nitropyrazole amide compound method
Tozawa et al. Enantioselective synthesis of 3, 4-dihydropyran-2-ones by chiral quaternary ammonium phenoxide-catalyzed tandem Michael addition and lactonization
US6596870B2 (en) Asymmetric synthetic methods based on phase transfer catalysis
CN108084050A (en) A kind of aluminium phosphate molecular sieve is catalyzed imines synthetic method
JP2007238540A (en) Method for producing optically active alcohol compound
CN111943874B (en) Aryl naproxen derivative high-valence iodine compound and preparation method and application thereof
CN108659028B (en) (Z) -type fluoroalkyl alkenyl borate and preparation method and application thereof
CN112920134A (en) Novel asymmetric catalytic fluorination reaction system and application thereof
KR20190016820A (en) Process for Preparing Latanoprostene bunod and Intermediate Therefor
JP6213999B2 (en) Amine compound, optically active amine, asymmetric catalyst containing optically active amine, and method for producing optically active halogen compound using asymmetric catalyst
CN117185965A (en) Preparation method of sulfonic acrylic acid salt compound surfactant
CN112876376B (en) Synthesis method of allyl aryl compound
CN115850076A (en) Method for introducing difluoromethylene into allyl ester compound aromatic ring
CN109456219B (en) Method for stably and efficiently preparing N-acrylamide compound
CN115340446B (en) Chiral benzocyclobutene alcohol, synthesis method and application thereof
CN115611692B (en) Method for synthesizing fluorine-containing compound
Miao et al. Copper-Mediated Fluorination for Preparing Aryl Fluorides

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant